Aigen Investment Management, LP

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1741224 NEW YORK, NY

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,701,631

+$1,809,195 QoQ

Shares Held

7,452

+75.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

1.02%

of 13F equity value

Holder Rank

#538

of 1,735 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Aigen Investment Management, LP holds $12,762,383 across 22 Biotechnology names. VRTX ranks #1 (29.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	7,452	$3,701,631
2	INCY	Incyte Corp	23,563	$2,671,101
3	INSM	INSMED Inc	16,847	$1,796,227
4	ASND	Ascendis Pharma A/S	4,073	$1,086,350
5	AXSM	Axsome Therapeutics, Inc.	2,390	$585,000
6	SMMT	Summit Therapeutics Inc.	24,477	$356,629
7	JANX	Janux Therapeutics, Inc.	22,841	$350,837
8	XENE	Xenon Pharmaceuticals Inc.	5,218	$314,958

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,701,631	7,452	+75.8%	Shares	Sole	2026-08-14
2026-03-31	$1,892,436	4,238	+374.0%	Shares	Sole	2026-05-15
2025-12-31	$405,303	894	-29.8%	Shares	Sole	2026-02-13
2024-06-30	$597,149	1,274	-70.8%	Shares	Sole	2024-08-09
2023-06-30	$1,533,623	4,358	-34.9%	Shares	Sole	2023-08-14
2022-09-30	$1,937,601	6,692	+432.8%	Shares	Sole	2022-11-09
2022-06-30	$353,928	1,256	-69.1%	Shares	Sole	2022-08-02
2021-12-31	$891,356	4,059	-57.4%	Shares	Sole	2022-02-11
2021-09-30	$1,727,558	9,524	-68.4%	Shares	Sole	2021-11-12
2021-06-30	$6,075,313	30,131	+44.2%	Shares	Sole	2021-08-10
2020-09-30	$5,687,035	20,899	-27.2%	Shares	Sole	2020-11-06
2020-06-30	$8,332,767	28,703	+5.5%	Shares	Sole	2020-08-10
2020-03-31	$6,475,571	27,214	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.